600 patients66,869 observations120 daysLIVE

Patient P-01760

Synthetic patientNBL-101 · Day 111 · 45–54 · M · baseline S14Steering view · 3DOpen companion preview
Therapy response
Unstable
Tolerance
Stable
GI state
Unstable
Inflammatory state
Unstable
Nutritional resilience
Unstable
Discontinuation risk
96%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 NBL-101 startedBaseline state S14
  2. Day 50 Trajectory diverged from predictionObserved response fell below the model's expected path.

What changed?

Trajectory began diverging from predicted response on Day 50.

Primary contributors, last 14 days
  • Treatment adherence+5
  • Inflammatory activity+4
  • GI instability+3

What helped?

No interventions yet.

    LIFE OS recommendation
    GI Support Protocol GI-04
    92%
    probability of meaningful tolerance improvement
    • 284 similar trajectories
    • 83% showed improvement
    • median effect visible after 8 days

    Daily trackers

    Molecule settings

    The trackers this program marks as important, last 14 days vs the 14 before.

    GI burden
    Companion
    65.1/100
    worsening · +4.9 vs previous 14 d
    Toxicity
    Blood
    52.8/100
    improving · -2.4 vs previous 14 d
    Sleep quality
    Wearable
    19.2/100
    worsening · -0.8 vs previous 14 d
    Energy level
    Daily log
    2.4/10
    worsening · -0.1 vs previous 14 d
    Stress level
    Daily log
    7/10
    stable · -0.0 vs previous 14 d
    Steps
    Wearable
    300
    worsening · -152 vs previous 14 d
    Adherence
    Companion
    42.5 %
    worsening · -2.8 vs previous 14 d
    This trajectory is decaying — what would help, what would not
    Steering view →

    Heading towards failing · 18 from the failing basin, 74 from restoration.

    Would help
    • GI-04 GI Support Protocol
      73% improved among 124 similar · onset 8 d · confidence 97%
    • ME-01 Monitoring Escalation
      100% improved among 77 similar · onset 3 d · confidence 73%
    • NP-02 Dietary Support Protocol
      63% improved among 64 similar · onset 10 d · confidence 73%
    Would not help
    • Keep histamine low
      GI +3.6 next day on high-intake days · n 20
    • Keep alcohol low
      GI +3.6 next day on high-intake days · n 18
    • Keep fat low
      GI +3.5 next day on high-intake days · n 25
    State influencers · digestive

    Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

    • Histamine load
      +3.6detractor · 95%
    • Alcohol
      +3.6detractor · 95%
    • Dietary fat load
      +3.5detractor · 95%
    • Simple carbohydrates
      +3.1detractor · 95%
    • Spicy / capsaicin
      +2.4detractor · 84%
    • Insoluble fibre
      -0.8no signal · 22%

    Biological layers

    Which pathways look influenced, and by which layer of this person's biology.

    Pathways under pressure
    • Mucosal barrier integrity 90
      • DNAFUT2 non-secretor lowers mucosal fucosylation
      • MicrobiomeAkkermansia low → thinner mucus layer
      • Daily logGI symptom score 65 and rising
      • WearableSleep 5.9 h, below personal baseline
    • Inflammatory signalling 85
      • DNAIL6 -174 variant raises baseline inflammatory tone
      • MicrobiomeBacteroides fragilis expansion
      • BloodInflammatory load index 65
      • WearableHRV 21 ms, trending down
    • Butyrate / short-chain fatty acid production 80
      • MicrobiomeButyrate capacity 42/100
      • MicrobiomeF. prausnitzii depleted
      • Daily logFibre intake low in recent food logs
    • Autonomic recovery 65
      • WearableResting HR 85 bpm
      • Wearable300 steps/day
      • WearableShort sleep window
    • Drug metabolism and exposure 20
      • BloodToxicity index 53
    DNA
    Fictional pharmacogenomic panel
    • FUT2 rs601338 AA (non-secretor)
      Reduced mucosal fucosylation
    • IL6 -174 G/C
      Higher inflammatory tone
    • CYP2D6 Normal metabolizer
      Expected exposure
    • MTHFR C677T
      Reduced folate turnover
    Microbiome
    Shannon diversity 1.9 · butyrate capacity 42/100
    • Akkermansia muciniphilaLow
    • Faecalibacterium prausnitziiLow
    • Bacteroides fragilisHigh
    • Bifidobacterium longumLow
    • EnterobacteriaceaeNormal
    Wearable, last 14 days
    daily evolution fed into the runtime
    HRV
    16 ms
    Sleep
    6.0 h
    Steps
    582
    Resting HR
    88 bpm
    Daily log: GI score 65, nutritional resilience 37, adherence 43.

    What this patient sees in NostraAI

    The content that steers the trajectory: what to eat, what to do, what to take.

    Open companion preview
    What to eat
    • Prepare a plain, low-fat pasta or rice meal and note how it feels afterwards
    • Choose a freshly cooked, lean protein; avoid frying, rich sauces and leftovers for now
    • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
    • Avoid known triggers for now: fried or oily food, dairy, alcohol
    What to do
    • Track each bowel movement today: time, stool form, urgency, overnight waking
    • A 15-minute walk after lunch
    • Protect a 7.5-hour sleep window; screens off 30 minutes before
    • Keep hydration steady: small amounts through the day rather than large volumes at once
    What to take
    • Take the scheduled dose as agreed with your care team
    • Electrolyte solution, one sachet after any loose stool
    • Fictional demo item: oral nutrition supplement with lunch

    284 biologically similar trajectories

    Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

    PatientSimilarityBaselineInterventionOutcomeResponse today
    P-0145457%S14GI-04no change49
    P-0160557%S14ME-01improved41
    P-0165554%S14GI-04no change29
    P-0140753%S14NP-02no change44
    P-0175153%S14ME-01improved48
    P-0182253%S1437
    P-0165652%S14ME-01improved41
    P-0181352%S01NP-02no change40
    P-0186552%S14NP-02no change51
    P-0186652%S1440
    P-0173251%S14ME-01improved45
    P-0187251%S14NP-02improved47